We are live on
!
Find out more
AF
Avanza Fonder Portfolio holdings
AUM
$4.59B
1-Year Est. Return
41.03%
This Fund
S&P 500
This Quarter
Est. Return
+4.85%
1 Year Est. Return
+41.03%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.37B
AUM Growth
–
Cap. Flow
+$3.34B
Cap. Flow
% of AUM
99.29%
Top 10 Holdings %
Top 10 Hldgs %
44.5%
Holding
437
New
437
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$343M |
| 2 |
NVIDIA
NVDA
|
+$328M |
| 3 |
Microsoft
MSFT
|
+$220M |
| 4 |
Amazon
AMZN
|
+$181M |
| 5 |
Meta Platforms (Facebook)
META
|
+$87.9M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.63% |
| 2 | Consumer Discretionary | 15.57% |
| 3 | Financials | 12.19% |
| 4 | Healthcare | 11.63% |
| 5 | Communication Services | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
BridgeBio Pharma
BBIO
$15.6B
| $181K | 0.01% |
+6,581
| New | +$170K |
|
402
Revolution Medicines
RVMD
$38.7B
| $173K | 0.01% |
+3,950
| New | +$199K |
|
403
Neogen
NEOG
$2.69B
| $169K | 0.01% |
+13,936
| New | +$195K |
|
404
Cerus
CERS
$441M
| $169K | 0.01% |
+109,852
| New | +$189K |
|
405
Descartes Systems
DSGX
$6.56B
| $169K | 0.01% |
+1,035
| New | +$115K |
|
406
Kadant
KAI
$3.78B
| $160K | ﹤0.01% |
+464
| New | +$168K |
|
|
FOLD
407
DELISTED
Amicus Therapeutics
FOLD
| $157K | ﹤0.01% |
+16,652
| New | +$173K |
|
408
Quest Resource Holding
QRHC
$28M
| $150K | ﹤0.01% |
+23,128
| New | +$170K |
|
409
Liberty Media Series A
FWONA
$22.4B
| $145K | ﹤0.01% |
+1,729
| New | +$134K |
|
410
Darling Ingredients
DAR
$9.47B
| $145K | ﹤0.01% |
+4,311
| New | +$163K |
|
411
Harmony Biosciences
HRMY
$2.03B
| $145K | ﹤0.01% |
+4,200
| New | +$144K |
|
412
Palomar
PLMR
$3.58B
| $143K | ﹤0.01% |
+1,353
| New | +$137K |
|
413
Pacific Biosciences
PACB
$444M
| $140K | ﹤0.01% |
+76,408
| New | +$149K |
|
414
Janux Therapeutics
JANX
$932M
| $139K | ﹤0.01% |
+2,605
| New | +$138K |
|
415
Lennar Class B
LEN.B
$19.9B
| $131K | ﹤0.01% |
+1,046
| New | +$157K |
|
|
ONC
416
BeOne Medicines Ltd
ONC
$32.3B
| $125K | ﹤0.01% |
+675
| New | +$138K |
|
417
Alarm.com
ALRM
$2.76B
| $120K | ﹤0.01% |
+1,975
| New | +$118K |
|
418
Krystal Biotech
KRYS
$8.86B
| $119K | ﹤0.01% |
+759
| New | +$135K |
|
419
GXO Logistics
GXO
$5.71B
| $117K | ﹤0.01% |
+2,687
| New | +$148K |
|
420
Summit Therapeutics
SMMT
$10.4B
| $115K | ﹤0.01% |
+6,445
| New | +$125K |
|
421
Energy Recovery
ERII
$457M
| $107K | ﹤0.01% |
+7,274
| New | +$124K |
|
|
ONT
422
Onterris Inc
ONT
$790M
| $105K | ﹤0.01% |
+5,660
| New | +$119K |
|
423
Core & Main
CNM
$8.62B
| $96.8K | ﹤0.01% |
+1,902
| New | +$89.6K |
|
424
Bright Horizons
BFAM
$4.07B
| $92.7K | ﹤0.01% |
+836
| New | +$101K |
|
425
Corbus Pharmaceuticals
CRBP
$165M
| $84.4K | ﹤0.01% |
+7,150
| New | +$120K |
|
Similar funds
SCM
AG
LNWTC
SV
ANTB
SCM
DWM
VCM
Avanza Fonder's Q4 2024 Portfolio in Review
Q4 2024 is the first quarter with a 13F filing on record for Avanza Fonder, which disclosed 437 positions worth $3.37B. Its ten largest holdings account for 44% of the portfolio.
Its largest position is Apple: 1,457,232 shares worth $365M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, followed by Consumer Discretionary and Financials.
- Avanza Fonder's largest Q4 2024 buy was Apple: 1,457,232 shares worth $365M.
- Avanza Fonder's ten largest holdings make up 44% of its $3.37B portfolio in Q4 2024.
- Avanza Fonder disclosed 437 positions in Q4 2024, its first 13F filing on record.
Based on Avanza Fonder's 13F filing for Q4 2024, filed 15 Jan 2025.